PHASE-I STUDY OF DEC-C2B8 [RITUXIMAB] IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL [CD20-HODGKINS-LYMPHOMA IN JAPAN(] NON)

Authors
OGURA M MORISHIMA Y KOBAYASHI Y SASAKI Y OHTSU T MURATE T KINOSHITA T TOBINAI K
Citation
M. Ogura et al., PHASE-I STUDY OF DEC-C2B8 [RITUXIMAB] IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL [CD20-HODGKINS-LYMPHOMA IN JAPAN(] NON), Experimental hematology, 25(8), 1997, pp. 407-407
Citations number
NO
Categorie Soggetti
Medicine, Research & Experimental",Hematology
Journal title
Experimental hematology → ACNP
ISSN journal
0301472X
Volume
25
Issue
8
Year of publication
1997
Pages
407 - 407
Database
ISI
SICI code
0301-472X(1997)25:8<407:PSOD[I>2.0.ZU;2-E